Aldeyra Therapeutics(FRA) 137

Market Cap€77.82M

Since IPON/A

5 YearN/A

1 YearN/A

1 MonthN/A

€1.26

-2.33%

-0.03Today

Aldeyra Therapeutics Financials at a Glance

Market Cap

€77.82M

Revenue (TTM)

€0.00

Net Income (TTM)

-€19.77

EPS (TTM)

-€0.33

P/E Ratio

-3.93

Dividend

€0.00

Beta (Volatility)

-0.19 (Low)

Dividend

€0.00

Beta (Volatility)

-0.19 (Low)

Price

€1.26

Volume

Open

€1.26

Price

€1.26

Volume

Open

€1.26

Previous Close

€1.26

Daily Range

€1.26 - €1.28

52-Week Range

€1.05 - €4.93

Estimated Earnings Date

N/A

Dividend

€0.00

Beta (Volatility)

-0.19 (Low)

Price

€1.26

Volume

Open

€1.26

Previous Close

€1.26

Daily Range

€1.26 - €1.28

52-Week Range

€1.05 - €4.93

Estimated Earnings Date

N/A

137 News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Aldeyra Therapeutics

Aldeyra Therapeutics, Inc. is a biotechnology company, which engages in research and development activities with related general business planning, including raising capital. It engages in the discovery of therapies designed to treat immune-mediated diseases. The company was founded by Thomas A. Jordan and John E. Dowling on August 13, 2004 and is headquartered in Lexington, MA.

Industry

Biotechnology

Sector

Health Care

Employees

CEO

Todd C. Brady, MD, PhD

Website

www.aldeyra.com

137 Financials

Key Financial Metrics (TTM)

Gross Margin

N/A

Operating Margin

N/A

Net Income Margin

N/A

Return on Equity

-49.28%

Return on Capital

N/A

Return on Assets

N/A

Earnings Yield

-25.45%

Dividend Yield

0.00%

Payout Ratio

N/A

Stock Overview

Market Cap

€77.82M

Shares Outstanding

60.33M

Volume

Avg. Volume

133.091

Financials (TTM)

Gross Profit

N/A

Operating Income

N/A

EBITDA

N/A

Operating Cash Flow

N/A

Capital Expenditure

N/A

Free Cash Flow

N/A

Cash & ST Invst.

N/A

Total Debt

N/A

Aldeyra Therapeutics Performance Analysis

Aldeyra Therapeutics annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	EUR 0	N/A
2023	2023-12-31	EUR 0	N/A
2024	2024-12-31	EUR 0	N/A
2025	2025-12-31	EUR 0	N/A

Aldeyra Therapeutics annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	EUR -1.01	11.7%
2023	2023-12-31	EUR -0.59	-41.7%
2024	2024-12-31	EUR -0.87	47.3%
2025	2025-12-31	EUR -0.50	-42.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

€0.00

N/A

Gross Profit

-€0.06

+1.1%

Gross Margin

N/A

Market Cap

€77.82M

N/A

Market Cap/Employee

€18.60

N/A

Employees

+0.8%

Net Income

-€4.69

+0.5%

EBITDA

-€4.97

+0.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

€39.56

-18.2%

Total Debt

€0.13

+0.0%

Accounts Receivable

N/A

Inventory

€0.00

N/A

Long Term Debt

€0.00

+0.0%

Short Term Debt

€0.13

+0.0%

Return on Assets

-34.69%

+0.7%

Return on Invested Capital

-47.24%

N/A

Free Cash Flow

-€3.99

+0.6%

Operating Cash Flow

-€3.97

+0.6%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

^GSPCS&P 500

^GSPCS&P 500$7,684.24-0.00%

^DJIDJI

^DJIDJI$53,254.61-0.01%

^IXICNASDAQ

^IXICNASDAQ$26,319.55-0.00%

BTCBitcoin

BTCBitcoin$78,890.00-0.00%

SPCXSPCX

SPCXSPCX$142.81+0.01%

AAPLAAPL

AAPLAAPL$315.25-0.01%

AMZNAMZN

AMZNAMZN$258.45-0.03%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

PCGPG&E

PCGPG&E$13.27-0.20%

NVDANvidia

NVDANvidia$220.78+0.01%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.97+0.11%

CNHCNH Industrial

CNHCNH Industrial$11.83+0.01%

NUNu Holdings

NUNu Holdings$14.55+0.02%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.63+0.02%

AALAmerican Airlines Group

AALAmerican Airlines Group$13.43-0.02%

Questions About 137

What is the current price of Aldeyra Therapeutics?

Aldeyra Therapeutics is trading at €1.26 per share.

What is the 52-week range for Aldeyra Therapeutics?

Over the past 52 weeks, Aldeyra Therapeutics has traded between €1.05 and €4.93.

How much debt does Aldeyra Therapeutics have?

As of the most recent reporting period, Aldeyra Therapeutics reported total debt of €125.47K.

How much cash does Aldeyra Therapeutics have on hand?

Aldeyra Therapeutics reported €39.44M in cash and cash equivalents in its most recent financial results.

What is Aldeyra Therapeutics’s dividend yield?

Aldeyra Therapeutics does not currently have a dividend yield.

Aldeyra Therapeutics(FRA) 137

Aldeyra Therapeutics Financials at a Glance

137 News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Aldeyra Therapeutics

137 Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Aldeyra Therapeutics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About 137

What is the current price of Aldeyra Therapeutics?

What is the 52-week range for Aldeyra Therapeutics?

How much debt does Aldeyra Therapeutics have?

How much cash does Aldeyra Therapeutics have on hand?

What is Aldeyra Therapeutics’s dividend yield?

Premium Investing Services